title: Solubility enhancement studies on lurasidone hydrochloride using mixed hydrotropy.
abstract: Low aqueous solubility is a major problem faced during formulation development of new drug molecules. Lurasidone HCl (LRD) is an antipsychotic agent specially used in the treatments of schizophrenia and is a good example of the problems associated with low aqueous solubility. Lurasidone is practically insoluble in water, has poor bioavailability and slow onset of action and therefore cannot be given in emergency clinical situations like schizophrenia. Hence, purpose of this research was to provide a fast dissolving oral dosage form of Lurasidone. This dosage form can provide quick onset of action by using the concept of mixed hydrotropy. Initially, solubility of LRD was determined individually in nicotinamide, sodium citrate, urea and sodium benzoate at concentration of 10, 20, 30 and 40% w/v solutions using purified water as a solvent. Highest solubility was obtained in 40% sodium benzoate solution. In order to decrease the individual hydrotrope concentration mixed hydrotropic agents were used. Highest solubility was obtained in 15:20:5 ratio of Nicotinamide + sodium benzoate + sodium citrate. This optimized combination was utilized in the preparation of solid dispersions by using distilled water as a solvent. Solid dispersions were evaluated for X-ray diffraction, differential scanning calorimetry and Fourier-transform infrared to show no drug-hydrotropes interaction has occurred. This solid dispersion was compressed to form fast dissolving tablets. Dissolution studies of prepared tablets were done using USP Type II apparatus. The batch L3 tablets show 88% cumulative drug release within 14 min and in vitro dispersion time was 32 min. It was concluded that the concept of mixed hydrotropic solid dispersion is novel, safe and cost-effective technique for enhancing the bioavailability of poorly water-soluble drugs. The miraculous enhancement in solubility and bioavailability of Lurasidone is clear indication of the potential of mixed hydrotropy to be used in future for other poorly water-soluble drugs in which low bioavailability is a major concern.
authors.affiliation: Department of Pharmaceutics, Sinhgad Technical Education Society's, Smt. Kashibai Navale College of Pharmacy, Pune, Maharashtra, India.
authors.forename: Jyotsana R
authors.initials: JR
authors.lastname: Madan
authors.affiliation: Department of Pharmaceutics, Sinhgad Technical Education Society's, Smt. Kashibai Navale College of Pharmacy, Pune, Maharashtra, India.
authors.forename: Kiran T
authors.initials: KT
authors.lastname: Pawar
authors.affiliation: Faculty of Medicine and Health, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.
authors.forename: Kamal
authors.initials: K
authors.lastname: Dua
keywords: Bioavailability; lurasidone; mixed hydrotropy; nicotinamide; solid dispersions
references.citation: J Pharm Sci. 2010 Sep;99(9):3953-65
references.pmid: 20607808
references.citation: Pharm Res. 2003 Jul;20(7):1022-30
references.pmid: 12880288
references.citation: Chem Pharm Bull (Tokyo). 1996 Nov;44(11):2121-7
references.pmid: 8945778
references.citation: Indian J Pharm Sci. 2011 Mar;73(2):179-83
references.pmid: 22303061
references.citation: Am J Psychiatry. 2011 Sep;168(9):957-67
references.pmid: 21676992
references.citation: J Clin Psychiatry. 2009 Jun;70(6):829-36
references.pmid: 19497249
references.citation: Iran J Pharm Res. 2010 Summer;9(3):233-42
references.pmid: 24363732